Anzeige
Mehr »
Mittwoch, 24.12.2025 - Börsentäglich über 12.000 News
Kein Weihnachtswunder - Blutuntersuchung ohne Blutabnahme!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0J35A | ISIN: AU000000EVE3 | Ticker-Symbol:
Branche
Konsumgüter
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
EVE HEALTH GROUP LIMITED Chart 1 Jahr
5-Tage-Chart
EVE HEALTH GROUP LIMITED 5-Tage-Chart

Aktuelle News zur EVE HEALTH GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.12.EVE HEALTH GROUP LIMITED: Change of Director's Interest Notice-
05.12.EVE HEALTH GROUP LIMITED: Change of Director's Interest Notice x 3-
05.12.EVE HEALTH GROUP LIMITED: Notification regarding unquoted securities - EVE1
05.12.EVE HEALTH GROUP LIMITED: Notification regarding unquoted securities - EVE2
EVE HEALTH GROUP Aktie jetzt für 0€ handeln
05.12.EVE HEALTH GROUP LIMITED: Application for quotation of securities - EVE2
04.12.EVE HEALTH GROUP LIMITED: Results of Meeting-
26.11.EVE HEALTH GROUP LIMITED: Becoming a substantial holder1
21.11.EVE HEALTH GROUP LIMITED: Change in substantial holding1
21.11.EVE HEALTH GROUP LIMITED: Change of Director's Interest Notice1
20.11.EVE Health Signs Telehealth Agreement with hubMed to Support Dyspro and Libbo Launches1
19.11.EVE HEALTH GROUP LIMITED: Spark Plus Investor Presentation-
19.11.EVE HEALTH GROUP LIMITED: EVE Signs Telehealth Services Agreement with hubMed -Revised-
18.11.EVE HEALTH GROUP LIMITED: EVE Signs Telehealth Services Agreement with hubMed-
05.11.EVE HEALTH GROUP LIMITED: Results of Meeting-
03.11.EVE HEALTH GROUP LIMITED: Notice of General Meeting/Proxy Form-
03.11.EVE HEALTH GROUP LIMITED: New Employee Incentives-
03.11.EVE Health Appoints Medical Science Liaison to Drive Clinical Engagement1
02.11.EVE HEALTH GROUP LIMITED: Medical Science Liaison Appointed-
31.10.EVE Health Enters Commercial Rollout Phase for Dyspro and Libbo Following First Prescriptions and Purchase Orders4
31.10.EVE HEALTH GROUP LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report1
Weiter >>
50 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1